Search Results - "AALAMIAN, Maryam"

Efficacy and safety of direct switch to indacaterol/glycopyrronium in patients with moderate COPD: the CRYSTAL open-label randomised trial by Vogelmeier, Claus F, Gaga, Mina, Aalamian-Mattheis, Maryam, Greulich, Timm, Marin, Jose M, Castellani, Walter, Ninane, Vincent, Lane, Stephen, Nunez, Xavier, Patalano, Francesco, Clemens, Andreas, Kostikas, Konstantinos

“…Dual bronchodilation combining a long-acting β -agonist (LABA) and a long-acting muscarinic antagonist (LAMA) is the preferred choice of treatment recommended…”
Get full text

Treatment response in COPD: does FEV1 say it all? A post hoc analysis of the CRYSTAL study by Kostikas, Konstantinos, Greulich, Timm, Mackay, Alexander J, Lossi, Nadine S, Aalamian-Mattheis, Maryam, Nunez, Xavier, Pagano, Veronica A, Patalano, Francesco, Clemens, Andreas, Vogelmeier, Claus F

“…The association between clinically relevant changes in patient-reported outcomes (PROs) and forced expiratory volume in 1 s (FEV1) in patients with chronic…”
Get full text

Efficacy and safety of serelaxin when added to standard of care in patients with acute heart failure: results from a PROBE study, RELAX‐AHF‐EU by Maggioni, Aldo P., López‐Sendón, José, Nielsen, Olav W., Hallén, Jonas, Aalamian‐Mattheis, Maryam, Wang, Yaqin, Ertl, Georg

“…Aim Serelaxin is a recombinant human relaxin‐2 hormone, which confers receptor‐mediated vasodilatation in a tissue‐specific fashion. The RELAX‐AHF‐EU study…”
Get full text

Inhibition of dendropoiesis by tumor derived and purified prostate specific antigen by Aalamian, Maryam, Tourkova, Irina L, Chatta, Gurkamal S, Lilja, Hans, Huland, Edith, Huland, Hartwig, Shurin, Galina V, Shurin, Michael R

“…Prostate specific antigen (PSA) is a serine protease produced by the prostate gland at high concentrations. Serum PSA may be significantly elevated in prostate…”
Get more information

Autologous renal cell cancer vaccines using heat shock protein-peptide complexes by Aalamian, Maryam, Fuchs, Ephraim, Gupta, Renu, Levey, Daniel L.

“…Investigations into the role of heat shock proteins (HSPs) in immune response have progressed well into a third decade, and indications of their use for the…”
Get full text

Autologous renal cell cancer vaccines using heat shock protein-peptide complexes : The status of cancer vaccine therapies in urology by AALAMIAN, Maryam, FUCHS, Ephraim, GUPTA, Renu, LEVEY, Daniel L

Get full text

Adoptive Transfer of T Cell Help Breaks Tolerance in Endogenous, Tumor-Specific CD8+ T Cells Responding to a Growing Tumor by Wang, Jie, Aalamian, Maryam, Jalla, Sanju, Luznik, Leo, Fuchs, Ephraim J.

“…Patients who reject allogeneic blood or marrow grafts after non-myeloablative conditioning sometimes develop delayed or sustained clinical disease responses,…”
Get full text

Human prostate cancer regulates generation and maturation of monocyte-derived dendritic cells by Aalamian, Maryam, Pirtskhalaishvili, Georgi, Nunez, Anthony, Esche, Clemens, Shurin, Galina V., Huland, Edith, Huland, Hartwig, Shurin, Michael R.

“…Background The progression of prostate cancer is accompanied by a marked suppression of the immune system, including the apoptotic death of dendritic cells…”
Get full text

Indacaterol/glycopyrronium reduces the risk of clinically important deterioration after direct switch from baseline therapies in patients with moderate COPD: a post hoc analysis of the CRYSTAL study by Greulich, Timm, Kostikas, Konstantinos, Gaga, Mina, Aalamian-Mattheis, Maryam, Lossi, Nadine S, Patalano, Francesco, Nunez, Xavier, Pagano, Veronica A, Fogel, Robert, Vogelmeier, Claus F, Clemens, Andreas

“…COPD is a progressive disease characterized by exacerbations and a decline in health status and lung function. Clinically important deterioration (CID) is a…”
Get full text

Human prostate cancer blocks the generation of dendritic cells from CD34+ hematopoietic progenitors by Shurin, G V, Aalamian, M, Pirtskhalaishvili, G, Bykovskaia, S, Huland, E, Huland, H, Shurin, M R

Get more information

Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING) by Marin, Jose M, Beeh, Kai M, Clemens, Andreas, Castellani, Walter, Schaper, Lennart, Saralaya, Dinesh, Gunstone, Anthony, Casamor, Ricard, Kostikas, Konstantinos, Aalamian-Mattheis, Maryam

“…Morning symptoms associated with COPD have a negative impact on patients' quality of life. Long-acting bronchodilators with rapid onset may relieve patients'…”
Get full text

Treatment response in COPD: does FEV 1 say it all? A post hoc analysis of the CRYSTAL study by Kostikas, Konstantinos, Greulich, Timm, Mackay, Alexander J, Lossi, Nadine S, Aalamian-Mattheis, Maryam, Nunez, Xavier, Pagano, Veronica A, Patalano, Francesco, Clemens, Andreas, Vogelmeier, Claus F

“…The association between clinically relevant changes in patient-reported outcomes (PROs) and forced expiratory volume in 1 s (FEV ) in patients with chronic…”
Get full text

Inhibition of dendritic cell generation and function by serum from prostate cancer patients: correlation with serum-free PSA by Aalamian-Matheis, Maryam, Chatta, Gurkamal S, Shurin, Michael R, Huland, Edith, Huland, Hartwig, Shurin, Galina V

“…Tumor produces a number of immunosuppressive factors that block maturation of dendritic cells (DCs). Here, we demonstrated that endogenous factors presented in…”
Get more information

Prostate cancer suppresses dendropoiesis both in vitro and in vivo by Aalamian, Maryam, Pirtskhalaishvili, Georgi, Yamabe, Kazuo, Esche, Clemens, Shurin, Galina, Heinzer, Hans, Huland, Edith, Huland, Hartwig, Shurin, Michael

Get full text